IgA nephropathy: challenges and opportunities.
Immunoglobulin A (IgA) nephropathy poses many challenges to investigators and physicians in its etiology, pathogenesis, prevention, and treatment. But at the same time, opportunities abound for new tests and treatments that may eventually lead to control of this common form of chronic kidney disease.
Glassock
Richard J
RJ
David Geffen School of Medicine, The University of California at Los Angeles, USA. glassock@cox.net